Brexpiprazole(CAS: 913611-97-9)

Brexpiprazole (CAS: 913611-97-9) is a selective serotonin receptor modulator (SSRMs) used primarily in the treatment of psychiatric disorders. It has the chemical formula C20H23FN4O and is known for its partial agonist activity at serotonin 5-HT1A receptors and antagonist activity at serotonin 5-HT2A receptors. This unique pharmacological profile makes it a valuable compound in modern psychopharmacology.

Brexpiprazole (CAS: 913611-97-9) is primarily used as a treatment for schizophrenia and major depressive disorder. It is also being explored for its potential in managing other mental health conditions such as anxiety and bipolar disorder. Its mechanism of action involves modulating serotonin receptor activity to improve symptoms of these disorders.

Brexpiprazole (CAS: 913611-97-9) is generally considered safe when used as directed, but like all medications, it may cause side effects. Common side effects include dizziness, somnolence, and weight changes. It is important to follow medical guidelines and consult healthcare professionals for proper handling and use. Safety standards are in place to ensure its appropriate application in clinical settings.

Brexpiprazole (CAS: 913611-97-9) should be stored in a cool, dry place away from direct light. It is typically kept at a temperature between 15°C and 30°C (59°F and 86°F). Proper storage ensures its stability and effectiveness. Keep the container tightly closed and ensure it is out of reach of children and unauthorized personnel.